Stock listing

A1W96L Stock Price, News, Filings & Events — Xencor, Inc.

Selected listing: A1W96L · LS · EUR · DE

The selected listing A1W96L:LS represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. Recently, Xencor has been involved in various clinical trials and collaborations aimed at advancing its innovative therapies. Investors can find the latest news, financial filings, and upcoming events related to the company's progress in the biopharmaceutical sector on this page. The market context reflects ongoing interest in novel treatments and the competitive landscape within the biotechnology industry.

A1W96L:LSEURDEUpdated July 21, 2026
Xencor, Inc. logo
Ticker
A1W96L:LS
Asset type
Stock
Market cap
$1.30B
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

Xencor, Inc. A1W96L:LS stock context

The selected listing A1W96L:LS represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. Recently, Xencor has been involved in various clinical trials and collaborations aimed at advancing its innovative therapies. Investors can find the latest news, financial filings, and upcoming events related to the company's progress in the biopharmaceutical sector on this page. The market context reflects ongoing interest in novel treatments and the competitive landscape within the biotechnology industry.

Research Xencor, Inc.

Alternate listings